Trial Profile
comparison of Therapy with Olmesartan medoxomil monotherapy or azelnidipine and olmesartan medoxomil combination in hypertensive patients with chronic KIdney disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Nov 2013
Price :
$35
*
At a glance
- Drugs Azelnidipine (Primary) ; Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms TOKI
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 05 Jun 2012 Planned end date 1 Jun 2013 added as reported by University Hospital Medical Information Network - Japan records.
- 05 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan records.